Related Experiment Video
Updated: May 27, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
SuperTarget goes quantitative: update on drug-target interactions.
Nikolai Hecker1, Jessica Ahmed, Joachim von Eichborn
1Structural Bioinformatics Group, Institute for Physiology, Charité-University Medicine Berlin, Lindenberger Weg 80, 13125 Berlin, Germany.
Nucleic Acids Research
|November 10, 2011
Summary
SuperTarget is a new web-based data warehouse that integrates comprehensive drug-target interaction data. It aids in understanding drug effects and identifying novel drug targets by analyzing complex biological networks.
Area of Science:
- Pharmacology
- Bioinformatics
- Computational Biology
Background:
- Understanding drug effects requires analyzing complex networks of drug-target interactions, including off-target effects and metabolic pathways.
- Identifying novel drug targets necessitates a thorough understanding of drug-target-pathway relationships.
Purpose of the Study:
- To develop a comprehensive web-based data warehouse, SuperTarget, for integrating and analyzing drug-related information.
- To facilitate drug screening, target identification, and understanding of drug mechanisms through a centralized data resource.
Main Methods:
- Developed SuperTarget, a web-based data warehouse integrating data on drug indications, adverse effects, metabolism, pathways, and Gene Ontology (GO) terms.
- Annotated over 6000 target proteins with more than 330,000 relations to 196,000 compounds, including binding affinities and literature sources.
- Implemented user-friendly tools for drug screening, target similarity analysis, and complex query capabilities.
Main Results:
- The SuperTarget database currently contains over 6000 target proteins and 196,000 compounds, with extensive relation data.
- The platform supports complex queries, such as identifying drugs targeting specific pathways or metabolized by particular enzymes.
- Binding affinities and literature pointers are included for the majority of drug-target interactions.
Conclusions:
- SuperTarget provides a valuable resource for researchers studying drug-target interactions and developing new therapeutics.
- The integrated data and query tools enable deeper insights into drug action, off-target effects, and novel target discovery.
- This platform enhances the understanding of complex drug-related biological networks.
More Related Videos
Related Concept Videos
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...